Figure 3.

Percentage of patients without diabetes (DM-), with mild diabetes (DM+) and with severe diabetes (DM++) receiving aldosterone receptor blockade therapy. On the left panel, results are shown for patients with preserved renal function (GFR >60 ml/min), and on the right panel for patients with reduced renal function.